Document Detail


Issues in transfusing preterm infants in the NICU.
MedLine Citation:
PMID:  15214254     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Decisions regarding whether or not to transfuse preterm infants in the neonatal intensive care unit are often difficult. Although numbers of red blood cell transfusions have decreased in recent years, transfusions are still a common occurrence. For each infant, the advantages of transfusion must be balanced against the consequences and potential risks. This article examines physiologic and iatrogenic causes of anemia in preterm infants, clinical consequences of anemia, the use of transfusions and their risks, and the role of erythropoietin therapy.
Authors:
Annamarie Bain; Susan Blackburn
Related Documents :
11896514 - Effect of recombinant erythropoietin on "late" transfusions in the neonatal intensive c...
10319054 - Long-term follow up of changes in fev1 and treatment intensity during pseudomonas aerug...
16734824 - Potential use of autologous umbilical cord blood red blood cells for early transfusion ...
19117884 - Neurodevelopmental outcome of extremely low birth weight infants randomly assigned to r...
12516744 - Hemorrhagic-ischemic cerebral injury in the preterm infant: current concepts.
22851494 - Has highly active antiretroviral therapy increased the time to seroreversion in hiv exp...
Publication Detail:
Type:  Comparative Study; Journal Article; Review    
Journal Detail:
Title:  The Journal of perinatal & neonatal nursing     Volume:  18     ISSN:  0893-2190     ISO Abbreviation:  J Perinat Neonatal Nurs     Publication Date:    2004 Apr-Jun
Date Detail:
Created Date:  2004-06-24     Completed Date:  2004-08-03     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8801387     Medline TA:  J Perinat Neonatal Nurs     Country:  United States    
Other Details:
Languages:  eng     Pagination:  170-82; quiz 183-4     Citation Subset:  N    
Affiliation:
Legacy Emanuel Children's Hospital, Neonatal Intensive Care Unit, 2801 N Gantenbein Ave, Portland, OR 97227, USA. ABain@LHS.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anemia, Neonatal / diagnosis,  therapy*
Blood Donors
Blood Transfusion / adverse effects,  methods*
Erythropoietin, Recombinant / therapeutic use
Female
Follow-Up Studies
Humans
Infant, Newborn
Infant, Premature*
Intensive Care Units, Neonatal
Male
Neonatal Nursing
Risk Assessment
Treatment Outcome
Chemical
Reg. No./Substance:
0/Erythropoietin, Recombinant

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Feeding issues for mothers of very low-birth-weight, premature infants through the first year.
Next Document:  Lysine fortification: past, present, and future.